series-c-plus
Stage
2015
Founded
1
Investors
About
Minghui Pharmaceutical is a late-stage clinical biopharmaceutical company developing and advancing a pipeline of therapeutic drug candidates. The company focuses on clinical development and preparing for global commercialization and recently closed a USD 131 million pre-IPO financing to support its late-stage programs.
Explore Minghui Pharmaceutical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.